×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CTNM – contineum therapeutics, inc. - common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CTNM
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/17
04:05 pm
ctnm
Contineum Therapeutics Announces Appointment of Diego Miralles, M.D. to Its Board of Directors
Medium
Report
Contineum Therapeutics Announces Appointment of Diego Miralles, M.D. to Its Board of Directors
3/13
12:35 pm
ctnm
Contineum Therapeutics, Inc. (NASDAQ: CTNM) is now covered by analysts at Jones Trading. They set a "buy" rating and a $23.00 price target on the stock.
Low
Report
Contineum Therapeutics, Inc. (NASDAQ: CTNM) is now covered by analysts at Jones Trading. They set a "buy" rating and a $23.00 price target on the stock.
3/12
04:05 pm
ctnm
Contineum Therapeutics to Present at the Stifel 2025 Virtual CNS Forum
Medium
Report
Contineum Therapeutics to Present at the Stifel 2025 Virtual CNS Forum
3/7
12:26 pm
ctnm
Contineum Therapeutics, Inc. (NASDAQ: CTNM) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $25.00 price target on the stock.
Medium
Report
Contineum Therapeutics, Inc. (NASDAQ: CTNM) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $25.00 price target on the stock.
3/7
09:22 am
ctnm
Contineum Therapeutics, Inc. (NASDAQ: CTNM) had its price target lowered by analysts at Robert W. Baird from $32.00 to $16.00. They now have an "outperform" rating on the stock.
Medium
Report
Contineum Therapeutics, Inc. (NASDAQ: CTNM) had its price target lowered by analysts at Robert W. Baird from $32.00 to $16.00. They now have an "outperform" rating on the stock.
3/6
04:42 pm
ctnm
Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones [Yahoo! Finance]
Medium
Report
Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones [Yahoo! Finance]
3/6
04:05 pm
ctnm
Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones
Medium
Report
Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones
3/4
04:45 pm
ctnm
Contineum Therapeutics Initiates Patient Dosing in Phase 1b Chronic Pain Trial of PIPE-791 [Yahoo! Finance]
Low
Report
Contineum Therapeutics Initiates Patient Dosing in Phase 1b Chronic Pain Trial of PIPE-791 [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
3/6/2025
04:05 pm
CTNM
contineum therapeutics, inc. - common stock
MISS
Report
5.1%
contineum therapeutics, inc. - common stock
3/6/2025
04:05 pm
CTNM
contineum therapeutics, inc. - common stock
MISS
Report
5.1%
contineum therapeutics, inc. - common stock
3/6/2025
04:05 pm
CTNM
contineum therapeutics, inc. - common stock
MISS
Report
5.1%
contineum therapeutics, inc. - common stock
3/6/2025
04:05 pm
CTNM
contineum therapeutics, inc. - common stock
MISS
Report
5.1%
contineum therapeutics, inc. - common stock
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/17
04:13 pm
ctnm
Form 4 Contineum Therapeutics, For: Mar 14 Filed by: Miralles Gines Diego
Medium
Report
Form 4 Contineum Therapeutics, For: Mar 14 Filed by: Miralles Gines Diego
3/17
04:10 pm
ctnm
Form 3 Contineum Therapeutics, For: Mar 14 Filed by: Miralles Gines Diego
Medium
Report
Form 3 Contineum Therapeutics, For: Mar 14 Filed by: Miralles Gines Diego
3/17
04:09 pm
ctnm
Form 8-K Contineum Therapeutics, For: Mar 14
Medium
Report
Form 8-K Contineum Therapeutics, For: Mar 14
3/6
04:14 pm
ctnm
Form S-8 Contineum Therapeutics,
Medium
Report
Form S-8 Contineum Therapeutics,
3/6
04:10 pm
ctnm
Form 10-K Contineum Therapeutics, For: Dec 31
Medium
Report
Form 10-K Contineum Therapeutics, For: Dec 31
3/6
04:08 pm
ctnm
Form 8-K Contineum Therapeutics, For: Mar 06
Medium
Report
Form 8-K Contineum Therapeutics, For: Mar 06
2/14
04:16 pm
ctnm
Form SCHEDULE 13G/A Contineum Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
Medium
Report
Form SCHEDULE 13G/A Contineum Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
2/14
10:50 am
ctnm
Form SCHEDULE 13G/A Contineum Therapeutics, Filed by: SECTORAL ASSET MANAGEMENT INC
Low
Report
Form SCHEDULE 13G/A Contineum Therapeutics, Filed by: SECTORAL ASSET MANAGEMENT INC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: